OTTAWA, ON, June 18, 2026 – The Canadian Venous Thromboembolism Research Network (CanVECTOR) is pleased to announce the recipients of the Fall 2025 Fellowship Funding Competition. These prestigious awards provide crucial salary to research fellows, fostering the next generation of leaders in thrombosis research across Canada.
CanVECTOR’s Fellowship Awards are made possible through the dedicated support of our network and valued partners. We are particularly proud to highlight key partnership with Thrombosis Canada, who long-standing investment in the Thrombosis Canada-CanVECTOR Fellowship Award has helped to advance a decade of excellence in clinical outcomes and knowledge translation research.
Following a rigorous and highly competitive peer-review process, two outstanding fellows have been awarded funding:
- Dr. Nicole Potere (University of Ottawa, Supervisor: Dr. Marc Carrier)
- Award: Thrombosis Canada – CanVECTOR Fellowship Award
- Project title: Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis: A Randomized Controlled Pilot Trial – The CONQUER-DVT Pilot Trial
- Focus: This pilot trial assesses the feasibility of conducting a large-scale Phase 3 randomized trial to determine whether low-dose colchicine administered for 6 months can successfully reduce post-thrombotic syndrome (PTS) and adverse vascular events following an acute proximal deep vein thrombosis (DVT) of the lower extremity.
- Dr. Ali Eshaghpour (McMaster University, Supervisor: Dr. Mark Crowther)
- Award: CanVECTOR Fellowship Award
- Project title: FIIX-IT: Factor II and X-based vitamin K antagonist monitoring in patients with mechanical heart valve
- Focus: This clinical study investigates how the innovative Fiix-NR assay compares to the standard International Normalized Ratio (INR) test in terms of concordance and feasibility for real-world clinical implementation in patients with mechanical heart valves who are receiving warfarin therapy.
These fellowships reflect CanVECTOR’s ongoing commitment to cultivating early-career expertise, supporting high-impact clinical research, and driving innovations that directly improve patient outcomes and safety in Canada and globally.
We extend our warmest congratulations to both recipients on their well-deserved success and look forward to the vital insights their research will bring to the thrombosis community.
Amye Harrigan & Miriam Kimpton – Co-Leads, Training & Mentoring platform
The CanVECTOR Team